pentobarbital will decrease the extent or effect of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with sturdy CYP3A4 inducers will not be advisable Keep track of Intently (2)pentobarbital will minimize the extent or effect of bupreno